Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2005 Jul;49(7):3028-30.
doi: 10.1128/AAC.49.7.3028-3030.2005.

Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosis

Joan Gavaldà  1 , María-Teresa Martín, Pedro López, Xavier Gomis, José-Luís Ramírez, Dolors Rodríguez, Oscar Len, Yolanda Puigfel, Isabel Ruíz, Albert Pahissa
Affiliations
Comparative Study

Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosis

Joan Gavaldà et al. Antimicrob Agents Chemother. 2005 Jul.

Abstract

The efficacy of therapeutic aerosolized amphotericin B (AMB) was studied in a steroid-immunosuppressed murine model of invasive pulmonary aspergillosis. Nebulized liposomal AMB can be a valid approach to the treatment of this infection, with subjects showing significantly improved survival relative to that of subjects given intravenous deoxycholate AMB, as well as lower lung weights and pulmonary glucosamine levels.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Effects of administration of nebulized d-AMB versus intravenous administration of d-AMB in steroid-immunosuppressed rats with experimental invasive aspergillosis. *, significant relative to value for control.
FIG. 2.
FIG. 2.
Effects of administration of nebulized L-AMB versus intravenous administration of L-AMB in steroid-immunosuppressed rats with experimental invasive aspergillosis. *, significant relative to value for control; †, significant relative to value for i.v. d-AMB; ‡, significant relative to value for nd-AMB.
See this image and copyright information in PMC

References

    1. Allen, S. D., K. N. Sorensen, M. J. Nejdl, C. Durrant, and R. T. Proffit. 1994. Prophylactic efficacy of aerosolized liposomal (AmBisome) and non-liposomal (Fungizone) amphotericin B in murine pulmonary aspergillosis. J. Antimicrob. Chemother. 34:1001-1013. - PubMed
    1. Becker, M. J., S. de Marie, M. H. Fens, W. C. Hop, H. A. Verbrugh, and I. A. Bakker-Woudenberg. 2002. Enhanced antifungal efficacy in experimental invasive pulmonary aspergillosis by combination of AmBisome with Fungizone as assessed by several parameters of antifungal response. J. Antimicrob. Chemother. 49:813-820. - PubMed
    1. Cicogna, C. E., M. H. White, E. M. Bernard, T. Ishimura, M. Sun, W. P. Tong, and D. Armstrong. 1997. Efficacy of prophylactic aerosol amphotericin B lipid complex in a rat model of pulmonary aspergillosis. Antimicrob. Agents Chemother. 41:259-261. - PMC - PubMed
    1. Denning, D. W. 1998. Invasive aspergillosis. Clin. Infect. Dis. 26:781-805. - PubMed
    1. Denning, D. W., C. C. Kibler, and R. A. Barnes on behalf of the British Society for Medical Mycology. 2003. British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections. Lancet Infect. Dis. 3:230-240. - PubMed

Publication types

MeSH terms

LinkOut - more resources